Results of molecular-cytogenetic studies in cases of suspected chronic myeloid leukemia
Abstract
Aim. Chronic myeloid leukemia (CML) is a myeloproliferative disease and one of the most common chronic myeloproliferative disorders. The main objective of this study was to investigate the frequency and characteristics of chromosomal changes in patients with suspected or confirmed CML based on the results from the scientific medical-genetic center “LeoGEN”. Methods. The methods used in this study include GTG-karyotyping, FISH (fluorescence in situ hybridization), and RT-PCR (reverse transcription-quantitative polymerase chain reaction). The research was conducted from January 2022 to October 2024. Results. FISH, GTG, and RT-PCR were performed on peripheral blood (PB) and bone marrow (BM) cells of 39 patients. FISH analysis using LSI BCR/ABL1 dual-color Cytocell probes was performed on 35 samples. In BM cells of 11 out of 39 individuals, the GTG method identified or ruled out chromosomal changes. RT-PCR was performed on 12 BM cell samples. Conclusions. The results demonstrate the necessity of incorporating molecular and cytogenetic methods into clinical practice to improve CML management and optimize treatment strategies. A comparison of CML research results using different methods is presented, highlighting the importance of their integrated application.
References
Heim S., Mitelman F. Cancer Cytogenetics. New York : Wiley-Liss, 1997. 316 p.
Tretyak N. M. Cytostatic and Supportive Therapy of Hemoblastoses: Treatment Standards. Kyiv : Avtograf, 2007. 174 p. [in Ukrainian]
Cianciulli A. M., Marzano R., Merola R., et al. Complex variant Philadelphia translocation involving the short arm of chromosome 9 in a case of chronic myeloid leukemia. Haematologica. 2004. Vol. 89. P. 127–128. https://doi.org/10.1155/2014/691630.
Cortes J. E., Talpaz M., O’Brien S. et al. Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal. Cancer. 2006. Vol. 106. P. 1306–1315. https://doi.org/10.1002/cncr.21745.
Van Dongen J., Macintyre E., Gabert J., et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia. Leukemia. 1999. Vol. 13. P. 1901–1928. https://doi.org/10.1038/sj.leu.2401592.
Pinkel D., Straume T., Gray J. W. Cytogenetic analysis using quantitative high sensitivity, fluorescence hybridization. Proceedings of the National Academy of Sciences of the United States of America. 1986. Vol. 83. P. 2934–2938. doi: 10.1073/pnas.83.9.2934.
Pienkowska-Grela B. Analiza cytogenetyczna w nowotworach hematoonko-logicznych. Poradnik. Warszawa, 2004. 59 p.
Cytogenetic Methods for Studying Human Chromosomes. Methodological Recommendations. Kyiv, 2003. 24 p. [in Ukrainian]
Wang H. C., Fedoroff S. Banding in human chromosomes treated with trypsin. Nature New Biology. 1972. Vol. 235. P. 52–53. https://doi.org/10.1038/newbio235052a0.
McGowan-Jordan J., Simons A., Schmid M., eds. International System for Human Cytogenomic Nomenclature (ISCN) 2020. Basel : Karger, 2020. https://doi.org/10.1159/isbn.978-3-318-06612-3.
GENMARK Sağlık Ürünleri. Instructions for use: geneMAP™ BCR-ABL11 p210 (Mbcr) IS-MMR Detection Kit. Issue 2.1. Istanbul, Turkey : Genmark Sağlık Ürünleri. 2021. 22 р.